Molecular Templates, Inc.
MTEM
MTEM was delisted on the 24th of December, 2024.
0 hedge funds and large institutions have $0 invested in Molecular Templates, Inc. in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
100% less funds holding
Funds holding: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $4 → $0 (-$4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Barclays
London,
United Kingdom
| – | -$4 | -102 | Closed |
|
MTEM Hedge Fund Activity: Q1 2025 in Review
0 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q1 2025, worth a combined $0 — down 100% from $4 a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of MTEM and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Barclays, exiting entirely with an estimated $4 sold.
- 0 institutional investors held Molecular Templates, Inc. (MTEM) as of Q1 2025, down from 3 in Q4 2024.
- Funds reported $0 of Molecular Templates, Inc. stock for Q1 2025, down 100% quarter-over-quarter.
- 0 funds opened new Molecular Templates, Inc. positions in Q1 2025 and 3 closed out, a net change of -3 holders.
- The largest Molecular Templates, Inc. seller in Q1 2025 was Barclays, an estimated $4 sold.
Based on aggregated 13F filings for Q1 2025.